AI x Healthcare

 

We are delighted to welcome Dr. Muriel Dahan, Director of Research & Development at Unicancer ; Dr. Stephane Chaillou, Chief Digital Information Officer at Institut Gustave Roussy ; and M. Yedidia Levy Zauberman, Senior Vice President of Public Affairs & Impact at Owkin, to this event. This gathering serves as a unique platform to bridge the French and Israeli ecosystems and accelerate AI-driven healthcare innovation. 

 

 

Israel has established itself as a global leader in artificial intelligence, boasting 2,200 specialized companies—nearly three times the number recorded 10 years ago. Among its most innovative sectors, digital healthcare stands out, with 58% of HealthTech companies integrating AI into their solutions.

 

• Medical imaging & assisted diagnosis – Cutting-edge algorithms enabling early disease detection.

• Drug discovery & development – Predictive modeling accelerating the creation of new therapies.

• Personalized medicine – Leveraging vast medical databases to tailor treatments.

• Preventive healthcare & telemedicine – AI-driven solutions optimizing risk prediction and care accessibility.

 

 

Israel also benefits from a unique advantage: extensive digitized medical records spanning over three decades and covering a population of 9 million. As a pioneer in Electronic Health Records and with the vast amount of healthcare data digitized by Israel’s healthcare providers over the last 30 years, the country has served as the launching pad for healthcare-focused AI startups, and continues to lead global efforts in medical data utilization and healthcare innovation.

 

 

• Foster collaborations between French and Israeli experts in AI-powered healthcare.

• Explore funding opportunities through Horizon Europe and bilateral agreements.

• Showcase French and Israeli advancements and their impact on the future of medicine.

 

---

 

 

• Ilana Cicurel, Director French Institute 

•Pr. Dan Peer, VP R&D Tel Aviv University

 

•Speaker: Prof. Ran Balicer

•Topic: The Role of AI in Transforming Healthcare

 

Moderator: Anat Naschitz, CEO 9xc / 9vc 

• Dr. Talia Cohen Solal, CEO Neurokaire 

• Dr. Muriel Dahan Director Research & Development Unicancer 

• Pr. Ran Balicer, Chief Innovation Officer, Clalit

• Dr. Stephane Chaillou, Chief Digital Information Officer, Gustave Roussy

• Pr. Noam Shomron, Faculty of Medicine – Tel Aviv University 

• Pr. Roded Sharan, Faculty of Exact Sciences – Tel Aviv University 

 

 

Moderator: Shai Melcer, Innovation Authority, Bioconvergence

• Mati Gill, CEO Aion Labs

• Yedidia Levy-Zauberman, VP Global Affairs Owkin (to be confirmed)

• Reprensentative from Sanofi / Teva or Astrazeneca (to be confirmed)

• 2 Israeli Startups

 

 

Closing Remarks:

Muriel Haim, Fondation France Israel

Aurelie Guthmann, Expertise France